Advertisement

Topics

Northwest Biotherapeutics, Inc. Company Profile

17:30 EST 18th November 2018 | BioPortfolio

Northwest Biotherapeutics is a biotechnology company focused on developing immunotherapy products to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, and on a cost-effective basis. The Company has two broad platform technologies: dendritic cell-based vaccines and therapeutic antibodies. The Company is focusing on development of its dendritic cell vaccines. The Company's lead clinical trial is a 240 patient double blind, randomized, placebo controlled Phase II trial in GBM. The trial remains open but is not currently enrolling patients. As part of the debt restructuring and ongoing fundraising activities, the Company expects to resume enrollment in this GBM trial later in the summer. The Company also received clearance from the FDA some time ago for a 600+ patient Phase III trial in prostate cancer, and clearance from the FDA for Phase I trials in five other cancers. The Company also conducted a Phase I/II trial with DCVax® for recurrent metastatic ovarian cancer. The Company's second technology platform, involving antibodies to CXCR4, is at the late pre-clinical development stage.


News Articles [339 Associated News Articles listed on BioPortfolio]

Northwest pedestrians admit to using their phones but insist they aren't distracted

SEATTLE, Oct. 17, 2018 /PRNewswire/ -- Travel down a typical Northwest street and you're likely to see a familiar scenario: pedestrians paying close attention to Read more...

Asterias Biotherapeutics to merge with BioTime

US-based biotechnology firms BioTime and Asterias Biotherapeutics have entered into a definitive merger agreement to form an integrated company focussed...Read More... The post Asterias Biotherapeutic...

Codexis Appoints Biotherapeutics R&D VP

Dr. Alaoui will be responsible for the biotherapeutics discovery pipeline and acceleration of drug candidates to the clinic

Bionow announced as a winner of the Northwest Cluster Mark

The 'Cluster Mark' is a new national initiative by central government being introduced to support the UK Manufacturing Strategy and as such is primarily aimed at recognising manufacturing excellence. ...

Cancer Research UK launches new research hub for biotherapeutics

Cancer Research UK has launched a global centre of excellence in London to facilitate research on biotherapeutics as a treatment...Read More... The post Cancer Research UK launches new research hub fo...

Device Analyzes Engine Oil On Trains; Eliminates Lab Analyses

Technology developed at the DOE’s Pacific Northwest National Laboratory (Richland, WA; 888-375-7665) and LRC Northwest (Richland) analyzes locomotive engine oil samples in situ...

Oregon researchers say sea pickles are adapting to the Pacific Northwest

(University of Oregon) Tubular colonial jellies known as pyrosomes that arrived in 2014 along North America's Pacific Northwest Coast appear to be adapting to cooler water and may become permanent res...

Pall and Celltheon form strategic biotherapeutics partnership

This partnership will deliver integrated manufacturing solutions for customers developing biotherapeutics

PubMed Articles [102 Associated PubMed Articles listed on BioPortfolio]

Synthetic Biology and Engineered Live Biotherapeutics: Toward Increasing System Complexity.

Recent advances in synthetic biology and biological system engineering have allowed the design and construction of engineered live biotherapeutics targeting a range of human clinical applications. In ...

Cell Penetration Profiling Using the Chloroalkane Penetration Assay.

Biotherapeutics are a promising class of molecules in drug discovery, but they are often limited to extracellular targets due to their poor cell penetration. High-throughput cell penetration assays ar...

Integrated BioTherapeutics.

Live bacterial biotherapeutics in the clinic.

Vaccination coverage and associated factors among children aged 12 - 23 months in Northwest Ethiopia.

Full vaccination coverage has been identified as the foundation for the prevention of morbidity and mortality from the childhood illnesses. However, a significant number of children do not get recomme...

Clinical Trials [35 Associated Clinical Trials listed on BioPortfolio]

Replication of the Teen Outreach Program in the Pacific Northwest

The Northwest Coalition for Adolescent Health (NWCAH) replicated the Teen Outreach Program (TOP) in five states across the pacific northwest including Idaho, Alaska, Montana, Oregon, and W...

Diet, Nutrient Status, and Food Insecurity

Arkansas has one of the highest rates for food insecurity and 27.7% of children in the University of Arkansas area are food insecure. In addition, more than 14% of children ages 2-4 are ob...

HIV and Sexually Transmitted Infection Prevention Intervention in the Northwest Territories

Indigenous youth are disproportionately represented in new HIV infection rates in Canada. Limited studies have evaluated longitudinal effects of arts-based approaches to HIV prevention wit...

Polarity Therapy for American Indian Caregivers of Dementia Patients

The purpose of this study is to assess the effectiveness of polarity therapy (PT), a complementary and alternative medicine treatment, in American Indian caregivers living in the Pacific N...

Safety and Pharmacokinetics Study of Anthrax Immune Globulin Intravenous (AIGIV)

The purpose of this study is to: - evaluate the safety profile of a single intravenous administration of AIGIV (containing either 3.5 mg/kg, 7.0 mg/kg or 14.0 mg/kg anti-PA IgG) a...

Companies [209 Associated Companies listed on BioPortfolio]

Northwest Biotherapeutics

Northwest Biotherapeutics (NWBT) is a biotechnology company focused on the clinical development of autologous immunotherapy products for cancer. Our technology platform, DCVax®, uses a patient’s ow...

Axial Biotherapeutics

Axial Biotherapeutics is a biopharmaceutical company harnessing the link between the human gut microbiome and the central nervous system to develop a new class of biotherapeutics ...

Northwest Biotherapeutics, Inc.

Northwest Biotherapeutics is a biotechnology company focused on developing immunotherapy products to treat cancers more effectively than current treatments, without toxicities of the kind associated w...

Epilepsy Foundation Northwest

The Epilepsy Foundation Northwest (EFNW) serves northwest states including Washington and Oregon with support to Alaska and Montana, and is an affiliate of the national Epilepsy Foundation. Over 110,...

Northwest Kinetics, Inc

Northwest Kinetics is an independent research facility specializing in Phase 0, I and II clinical research services. Founded in 1995, we are the only facility of our size in the Seattle-Tacoma area, a...

More Information about "Northwest Biotherapeutics, Inc." on BioPortfolio

We have published hundreds of Northwest Biotherapeutics, Inc. news stories on BioPortfolio along with dozens of Northwest Biotherapeutics, Inc. Clinical Trials and PubMed Articles about Northwest Biotherapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Northwest Biotherapeutics, Inc. Companies in our database. You can also find out about relevant Northwest Biotherapeutics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record